Robert Tipp, Chief Investment Strategist at PGIM Fixed Income, on potential Fed rate cuts and current investment outlook. Dr. Phil Chan, CEO of CytoSorbents (NASDAQ: CTSO), discusses the medical issues surrounding the coronavirus threat, and their technology that can treat compromised immune systems. Michael Tiedemann, CEO of Tiedemann Advisors, on how they’re advising clients in the sell-off. Brian Chappatta on his column: "Bond Traders See Fed Facing All-or-Nothing Call." Hosted by Lisa Abramowicz and Paul Sweeney.

Special Edition: Nvidia CEO Jensen Huang on Investing in South Korea
14:41

Amex Expenses Surge 12% as Marketing Costs for Cards Rise
23:34

Tesla Plunges Most in a Year on Investor Angst Over AI Spending
20:58